In the latter case, Teneurin-1 expression was further associated with extra-thyroidal invasion, an advanced disease stage, the risk of recurrence, and the presence of BRAF V600E, an actionable mutation with a known prognostic significance in this cancer. The gene discussed is TENM1; the disease is cancer.